Spontaneous regression of tumour and the role of microbial infection - possibilities for cancer treatment

Anti-Cancer Drugs

Volumn 27, Issue 4, 2016, Pages 269-277

  Kucerova, Petra ^a   Cervinkova, Monika ^a  

^a INSTITUTE OF ANIMAL PHYSIOLOGY AND GENETICS   (Czech Republic)

Author keywords

Bacillus Calmette Guerin vaccine; Cancer; Clostridium spp.; Coley's toxin; Microorganisms; Spontaneous regression; Treatment

Indexed keywords

COLEYS TOXIN; TOXIN; UNCLASSIFIED DRUG; BACTERIAL TOXIN; BCG VACCINE;

ANAEROBIC BACTERIUM; BACTERIAL INFECTION; BIFIDOBACTERIUM; CANCER REGRESSION; CANCER THERAPY; CLINICAL PRACTICE; CLOSTRIDIUM; ENZYME PRODRUG THERAPY; HUMAN; IMMUNE SYSTEM; LACTOBACILLUS; MALIGNANT NEOPLASTIC DISEASE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; BACTERIAL PHENOMENA AND FUNCTIONS; GENE THERAPY; GENETICS; HISTORY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASMS; TUMOR REGRESSION;

BACTERIAL PHYSIOLOGICAL PHENOMENA; BACTERIAL TOXINS; BCG VACCINE; BIFIDOBACTERIUM; CLOSTRIDIUM; COMBINED MODALITY THERAPY; GENETIC THERAPY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, ANCIENT; HUMANS; LACTOBACILLUS; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASMS; SALMONELLA;

EID: 84961200129     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000337     Document Type: Review

References (59)

1. Bunting A. Genetically engineered bacteria as cancer fighting agents. Univ Ottawa J Med 2013; 3:26-33.
2. Jessy T. Immunity over inability: The spontaneous regression of cancer. J Nat Sci Biol Med 2011; 2:43-49.
3. Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, et al. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol 2013; 190:469-478.
4. Abdulamir AS, Hafidh RR, Abu Bakar F. The tumoricidal activity of Salmonella and its role in treating cancers. Cancer Ther 2013; 8:10-23.
5. Sengupta N, MacFie TS, MacDonald TT, Pennington D, Silver AR. Cancer immunoediting and ''spontaneous'' tumor regression. Pathol Res Pract 2010; 206:1-8.
6. Thomas JA, Badini M. The role of innate immunity in spontaneous regression of cancer. Indian J Cancer 2011; 48:246-251.
7. Mager DL. Bacteria and cancer: Cause, coincidence or cure? A review. J Transl Med 2006; 4:14.
8. Hoption Cann SA, Van Netten JP, Van Netten C. DrWilliam Coley and tumour regression: A place in history or in the future. Postgrad Med J 2003; 79:672-680.
9. Hoption Cann SA, Van Netten JP, Van Netten C. Acute infections as a means of cancer prevention: Opposing effects to chronic infections? Cancer Detect Prev 2006; 30:83-93.
10. Wei MQ, Mengesha A, Good D, Anné J. Bacterial targeted tumour therapy-dawn of a new era. Cancer Lett 2008; 259:16-27.
11. Paton AW, Morona R, Paton JC. Bioengineered microbes in disease therapy. Trends Mol Med 2012; 18:417-425.
12. Kok-Ho H. Spontaneous regression of cancer: A therapeutic role for pyrogenic infections? AMSJ 2012; 3:30-33.
13. Jain RK, Forbes NS. Can engineered bacteria help control cancer? Proc Natl Acad Sci USA 2001; 98:14748-14750.
14. Chakrabarty AM. Microorganisms and cancer: Quest for a therapy. J Bacteriol 2003; 185:2683-2686.
15. Ramasamy S, Nattarayan V, Jayaraj GG, Arulanandh MD, Jaiswal A. Bacterial infection-mediated anticancer activity (BIMAc)-revisiting the molecular mechanisms. J Med Hypotheses Ideas 2012; 6:19-22.
16. Kim CJ, Dessureault S, Gabrilovich D, Reintgen DS, Slingluff CL Jr. Immunotherapy for melanoma. Cancer Control 2002; 9:22-30.
17. Karpiński TM, Szkaradkiewicz AK. Anticancer peptides from bacteria. Bangladesh J Pharmacol 2013; 8:343-348.
18. Chorobik P, Czaplicki D, Ossysek K, Bereta J. Salmonella and cancer: From pathogens to therapeutics. Acta Biochim Pol 2013; 60:285-297.
19. Paterson Y, Guirnalda PD, Wood LM. Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy. Semin Immunol 2010; 22:183-189.
20. Mukaratirwa S, Chitanga S, Chimatira T, Makuleke C, Sayi ST, Bhebhe E. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: Therapeutic efficacy and histological changes. J S Afr Vet Assoc 2009; 80:92-96.
21. Taniguchi S, Fujimori M, Sasaki T, Tsutsui H, Shimatani Y, Seki K, et al. Targeting solid tumors with non-pathogenic obligate anaerobic bacteria. Cancer Sci 2010; 101:1925-1932.
22. Li Z, Fallon J, Mandeli J, Wetmur J, Woo SL. A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer. J Natl Cancer Inst 2008; 100:1389-1400.
23. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc Natl Acad Sci USA 2002; 99:14098-14103.
24. Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK. Bacteria in cancer therapy: A novel experimental strategy. J Biomed Sci 2010; 17:21.
25. Mangesha A. Use of non-pathogenic bacteria as vectors for targeted gene expression in cancer gene therapy [dissertation]. the NetherlandsMaastricht University, 2009.
26. Sen PP, Gautham A, Manavalan M, Najeeb MA. Bacteria in cancer therapy: An emerging robust therapy. Int Res J Pharm 2013; 4:1-4.
27. Seow SW, Cai S, Rahmat JN, Bay BH, Lee YK, Chan YH, et al. Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci 2010; 101:751-758.
28. Chang WW, Lee CH. Salmonella as an innovative therapeutic antitumor agent. Int J Mol Sci 2014; 15:14546-14554.
29. Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, et al. Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-a. PLoS One 2009; 4:e6692.
30. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, et al. Tumor targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005; 102:755-760.
31. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007; 104:10170-10174.
32. Zhao M, Yang M, Ma H, Li X, Tan X, Li S, et al. Targeted therapy with a Salmonella typhimurium leucine arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006; 66:7647-7652.
33. Zhang Y, Tome Y, Suetsugu A, Zhang L, Zhang N, Hoffman RM, et al. Determination of the optimal route of administration of Salmonella typhimurium A1 R to target breast cancer in nude mice. Anticancer Res 2012; 32:2501-2508.
34. Zhang Y, Miwa S, Zhang N, Hoffman RM, Zhao M. Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis. Oncotarget 2015; 6:2615-2622.
35. Uchugonova A, Zhao M, Zhang Y, Weinigel M, König K, Hoffman RM. Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice. Anticancer Res 2012; 32:4331-4337.
36. Liu F, Zhang L, Hoffman RM, Zhao M. Vessel destruction by tumor targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 2010; 9:4518-4524.
37. Matsumoto Y, Miwa S, Zhang Y, Hiroshima Y, Yano S, Uehara F, et al. Efficacy of tumor-targeting Salmonella typhimurium A1 R on nude mouse models of metastatic and disseminated human ovarian cancer. J Cell Biochem 2014; 115:1996-2003.
38. Matsumoto Y, Miwa S, Zhang Y, Zhao M, Yano S, Uehara F, et al. Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice. Oncotarget 2015; 6:11369-11377.
39. Hiroshima Y, Zhang Y, Zhang N, Maawy A, Mii S, Yamamoto M, et al. Establishment of a patient-derived orthotopic xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS One 2015; 10:e0117417.
40. Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, et al. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009; 29:1873-1878.
41. Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, et al. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 2010; 164:248-255.
42. Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, Uehara F, et al. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 2013; 12:2774-2780.
43. Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, et al. Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer. Cancer Immunol Res 2013; 1:123-133.
44. Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, et al. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenografts (PDOX). J Cell Biochem 2014; 115:1254-1261.
45. Hiroshima Y, Zhang Y, Murakami T, Maawy A, Miwa S, Yamamoto M, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenografts (PDOX) and cell-line mouse models. Oncotarget 2014; 5:12346-12357.
46. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 2009; 8:870-875.
47. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009; 106:992-998.
48. Miwa S, Zhang Y, Baek KE, Uehara F, Yano S, Yamamoto M, et al. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R. Oncotarget 2014; 5:12849-12861.
49. Hiroshima Y, Zhao M, Zhang Y, Zhang N, Maawy A, Murakami T, et al. Tumortargeting Salmonella typhimurium A1-R arrests a chemo-resistant patient soft-tissue sarcoma in nude mice. PLoS One 2015; 10:e0134324.
50. Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, et al. Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif 2010; 43:41-48.
51. Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, et al. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 2012; 11:628-632.
52. Lehouritis P, Springer C, Tangney M. Bacterial-directed enzyme prodrug therapy. J Control Release 2013; 170:120-131.
53. Bizzarri AR, Santini S, Coppari E, Bucciantini M, Di Agostino S, Yamada T, et al. Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy. Int J Nanomed 2011; 6:3011-3019.
54. Wolf P, Elsasser-Beile U. Pseudomonas exotoxin A: From virulence factor to anti-cancer agent. Int J Med Microbiol 2009; 299:161-176.
55. Zhang Y, Schulte W, Pink D, Phipps K, Zijlstra A, Lewis JD, et al. Sensitivity of cancer cells to truncated diphtheria toxin. PLoS One 2010; 5:e10498.
56. Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, et al. Functional and structural characteristics of anticancer peptide Pep27 analogues. Cancer Cell Int 2005; 5:21.
57. Hoption Cann SA, Van Netten JP, Van Netten C, Glover DW. Spontaneous regression: A hidden treasure buried in time. Med Hypotheses 2002; 58:115-119.
58. Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother 2001; 50:391-396.
59. Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP. Infection and cancer: Revaluation of the hygiene hypothesis. Clin Cancer Res 2013; 9:2834-2841.